|
|
|
|
| Mikart’s 50 years of experience as a CDMO in oral solid and nonsterile oral liquid dosage forms, combined with our specialization in pediatric, geriatric, and controlled-substance products, make us an ideal partner from formulation development through commercialization. We prioritize long-lasting relationships and a personalized, hands-on approach — delivering the reliability, technical expertise, and flexibility needed to meet your goals, navigate complexity, and consistently exceed expectations at every stage. |
|
|
|
| Powder Rheology: Gateway For Tablet Sticking Insights | Application Note | By Devang Patel, Kerry Cruz, et al., Natoli Engineering Company, Inc. | Powder rheology offers a scientific method to predict and mitigate tablet sticking issues, helping to ensure smoother pharmaceutical production cycles through early material and tooling selection. |
|
|
| How We've Evolved To Meet The Changing Needs Of Biotechs | Article | By Richard Johnson, Upperton Pharma Solutions | CDMOs have shifted from transactional vendors to integrated scientific partners, supporting early development, regulatory strategy, advanced technologies, and faster paths from concept to clinic. |
|
|
|
|
|
|
By Louis Garguilo, chief editor, Outsourced Pharma | It sets off a real tension – ideological, economic, even personal. But what would happen if the U.S. government cut direct financial support for “biotechnology research,” leaving it entirely to investors, private and public markets, and bigger pharma? "Our industry’s mind-meld says with no government largesse our biotech industry collapses," writes Chief Editor Louis Garguilo. It's an "outlandish hypothetical," but he asks for a few minutes to go through this. And he has help in making his case. | |
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
| Performance Through Process Understanding | Webinar | Lonza | Explore the formulation and manufacturing considerations for amorphous solid dispersions (ASDs), with a focus on hot melt extrusion (HME) as a scalable and cost-effective technology option. |
|
|
| Spray Dried Dispersions In Controlled Release Formulations | White Paper | By Michael Grass, Ph.D. and David Vodak, Ph.D., Bend Bioscience | Integrating spray dried dispersions with CR strategies addresses poor drug solubility and the need for tailored release kinetics. Explore considerations to ensure stability and sustained supersaturation. |
|
|
|
|
|
|
| Pharma and biopharma companies face urgent pressure to regionalize supply chains amid geopolitical and regulatory volatility. Join us on May 6th for a virtual event hosted by Outsourced Pharma & Orientation Marketing, featuring top CDMO CEOs and experts discussing multi-billion-dollar investments in U.S. and European capacity, strategies for mitigating geographic risk, and actionable insights on CDMO partnerships to ensure supply continuity, regulatory compliance, and scalable, flexible manufacturing in a rapidly changing global market. |
|
|
|
Laboratory Services | Alcami | Integrated lab services deliver method development, validation, and testing across modalities, supporting quality, compliance, and formulation progress from early development to commercialization. |
|
|
|
Regulatory Starting Materials (RSMs) — India | Pharma Expanse | We span nine sites across five countries, supporting discovery through commercial NCE programs with a cost-neutral model. Uncover our regulatory starting material capabilities. |
|
|
OUTSOURCED PHARMA CAPABILITIES UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
